Rapid-acting insulin analogues, insulin lispro and insulin aspart, offer faster absorption and quicker glucose control compared to regular insulin. These advancements improve postprandial glucose management and patient quality of life in diabetes treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: